IFN-γ and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy

Systemic administration of IL-12 and intermittent doses of IL-2 induce complete regression of metastatic murine renal carcinoma. Here, we show that overt tumor regression induced by IL-12/pulse IL-2 is preceded by recruitment of CD8(+) T cells, vascular injury, disrupted tumor neovascularization, an...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Wigginton, Jon M., Gruys, Eilene, Geiselhart, Lisa, Subleski, Jeffrey, Komschlies, Kristin L., Park, Jong-Wook, Wiltrout, Theresa A., Nagashima, Kunio, Back, Timothy C., Wiltrout, Robert H.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Clinical Investigation 2001
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC209333/
https://ncbi.nlm.nih.gov/pubmed/11435457
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky